Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010819 |
---|---|
Receipt number | R000012372 |
Scientific Title | Phase II study of adjuvant S-1 therapy for node-positive biliary cancer |
Date of disclosure of the study information | 2013/06/01 |
Last modified on | 2022/06/08 17:37:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/05/28 12:14:49 | ||
2 | Update | 2013/11/30 12:40:56 | TEL |
|
3 | Update | 2015/12/29 12:09:03 | Last follow-up date Other related information |
|
4 | Update | 2016/05/28 16:11:13 | Name of primary person or sponsor Organization |
|
5 | Update | 2016/05/28 16:13:51 | Recruitment status |
|
6 | Update | 2018/09/13 14:21:05 | Other related information |
|
7 | Update | 2022/06/07 08:01:05 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
8 | Update | 2022/06/08 13:31:31 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
9 | Update | 2022/06/08 13:34:33 | Recruitment status Date of IRB |
|
10 | Update | 2022/06/08 13:34:56 | Publication of results |
|
11 | Update | 2022/06/08 17:37:51 | Date of IRB |